The ReTA-model: Rehabilitation Trail for Workers on Long-term Sick Leave in the Healthcare Sector (ReTA-model)

March 30, 2022 updated by: Emma Hagqvist, Karolinska Institutet

Validation of the ReTA-model: Rehabilitation Trail for Workers on Long-term Sick Leave in the Healthcare

The ReTA-model is a rehabilitation model for return to work after long-term sickness absence (LTSA) due to stress or burnout. The ReTA-model will be validated in this trial among nurses and physicians currently in LTSA. The ReTA-model includes a three-week treatment with exercise, individual and collegial talks with psychology and lecturing. The control group will receive conventional rehabilitation from regular care.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The ReTA-model is a rehabilitation model for return to work after long-term sickness absence (LTSA) due to stress or burnout. The ReTA-model will be validated in this trial among nurses and physicians currently in LTSA. The ReTA-model includes a three-week treatment with exercise, individual and collegial talks with psychology and lecturing. The control group will receive conventional rehabilitation from regular care.

Study Type

Interventional

Enrollment (Anticipated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Åke Nygren, MD

Study Locations

  • Sweden
    • Outside U.S. And Canada
      • Stockholm, Outside U.S. And Canada, Sweden, 171 77
        • Recruiting
        • Karolinska Institutet
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • currently on sick leave for burnout
  • employed in the Swedish healthcare services as a nurse or as a physician

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Will receive a rehabilitation intervention
Behavioral: ReTA-model
Validating the rehabilitation model ReTA
Active Comparator: Controll
Will receive conventional rehabilitation
Behavioral: ReTA-model
Validating the rehabilitation model ReTA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Return to work
Time Frame: 12 months
At work part or full-time compare to no return to work
12 months
Karolinska Exhaustion Disorder Scale KEDS
Time Frame: 12 months
Decreased points in the KEDS scale 1-19, qith higher scores reflecting greater exhaustion severity.
12 months
Symptom Checklist - 6
Time Frame: 12 months
Decreased points on the SCL-6 scale, with a higher number reflecting depression.
12 months
Montgomery Åsberg Depression Rating Scale
Time Frame: 12 months
Decreased points in the MADRAS scale with score ranging from 0 to 60, with higher scores reflecting greater depression severity.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Karolinska Institutet

Investigators

  • Principal Investigator: Emma Hagqvist, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Anticipated)

April 1, 2023

Study Completion (Anticipated)

September 1, 2023

Study Registration Dates

First Submitted

March 30, 2022

First Submitted That Met QC Criteria

March 30, 2022

First Posted (Actual)

April 6, 2022

Study Record Updates

Last Update Posted (Actual)

April 6, 2022

Last Update Submitted That Met QC Criteria

March 30, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ReTA-model

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout

Clinical Trials on ReTA-model

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe